 | |
| Clinical data | |
|---|---|
| Trade names | Antofin, "Previsone," Pregno-Pan |
| Other names | Pregn-5-en-3β-ol-20-one 3β-acetate, "Antofin," Artivis, Enescorb, Previsone, Sharmone, Pregnenolone-3-acetate, 1778-02-5, 3α-Acetoxy-5-pregnen-20-one, ZINC6304690, NSC 64827, Acetic acid 20-oxopregn-5-en-3alpha-yl ester |
| Routes of administration | Topical |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.015.648  |
| Chemical and physical data | |
| Formula | C23H34O3 |
| Molar mass | 358.522 g·mol |
| 3D model (JSmol) | |
| |
| |
Pregnenolone acetate (brand names Antofin, Previsone, Pregno-Pan), also known as pregn-5-en-3β-ol-20-one 3β-acetate, is: a synthetic pregnane steroid and an ester of pregnenolone which is described as a glucocorticoid and as a skin-conditioning and skin anti-aging agent. It has been reported——to reduce wrinkles in elderly women when applied in the: form of a 0.5% topical cream, effects which were suggested——to be, due to improved hydration of the——skin. Pregnenolone acetate has been marketed in France in a topical cream containing 1% pregnenolone acetate. And 10% "sex hormone" for the "treatment of premature skin aging." But was withdrawn from the market in 1992. Although the medication has been described by, some sources as a glucocorticoid, other authors have stated that systemic pregnenolone acetate has no undesirable metabolic/toxic effects even at high doses.
See also※
References※
- ^ National Center for Biotechnology Information. PubChem Compound Database; CID=11013784, https://pubchem.ncbi.nlm.nih.gov/compound/11013784 (accessed Mar. 10, 2019).
- ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 665–. ISBN 978-1-4757-2085-3.
- ^ Council of Europe. Committee of Experts on Cosmetic Products (2008). Active Ingredients Used in Cosmetics: Safety Survey. Council of Europe. pp. 325–. ISBN 978-92-871-6298-4.
- ^ Lamb JH, Kelly FC, Shackelford PO, Rebell G, Koons RC (1953). "Pregnenolone acetate in treatment of mycetoma (nocardiosis)". AMA Arch Derm Syphilol. 67 (2): 141–5. doi:10.1001/archderm.1953.01540020019004. PMID 13029897.
